Chirality of Drugs and Chiral Recognition

[RG #65] Chirality of Drugs and Chiral Recognition

November 1995 - August 1996

Organizer:

Israel Agranat (The Hebrew University of Jerusalem)

The notion of chirality has emerged as a major theme in drug design and discovery. Many of the new chiral drugs are being developed as single enantiomers. Chiral recognition is one of the most significant topics of contemporary stereochemical studies and is an essential component of pharmacological events.

1995-1996 Research Groups

Members

Israel Agranat

FELLOW

The Hebrew University of Jerusalem

Israel is a professor in the Department of Organic Chemistry at The Hebrew University of Jerusalem.

David Avnir

FELLOW

The Hebrew University of Jerusalem

David is a professor in the Department of Organic Chemistry at The Hebrew University of Jerusalem.

Robert Glaser

FELLOW

Ben-Gurion University of the Negev

Robert is a professor in the Department of Chemistry at Ben-Gurion of the Negev.

Bernard Green

FELLOW

The Hebrew University of Jerusalem

Bernard is a professor in the School of Pharmacy at The Hebrew University of Jerusalem. His research interests are: biorganic chemistry; catalytic antibodies; host-guest chemistry; clathrate inclusion chemistry; chirality phenomena.